Epilepsy Research

Real-world experience with GLP-1 receptor agonists in adults with epilepsy following a modified atkins diet

By Roba El Zibaoui, Tanya J. W. McDonald, Bobbie J. Henry-Barron, Diane Vizthum, Mackenzie C. Cervenka

Case series of 10 peopleInterventions

Declared no competing interests

The paper

Roba El Zibaoui, Tanya J. W. McDonald, Bobbie J. Henry-Barron, Diane Vizthum, Mackenzie C. Cervenka

Johns Hopkins University

Epilepsy Research, 14 Aug 2026

doi.org/10.1016/j.eplepsyres.2026.107896 PubMed 42617503

Neurology Genetics4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19